- Diagnosis and Clinical Features in Autoimmune-Mediated Movement Disorders
-
Pei-Chen Hsieh, Yih-Ru Wu
-
J Mov Disord. 2022;15(2):95-105. Published online May 26, 2022
-
DOI: https://doi.org/10.14802/jmd.21077
-
-
6,080
View
-
640
Download
-
1
Web of Science
-
2
Crossref
-
Abstract
PDF Supplementary Material
- Movement disorders are common manifestations in autoimmune-mediated encephalitis. This group of diseases is suspected to be triggered by infection or neoplasm. Certain phenotypes correlate with specific autoantibody-related neurological disorders, such as orofacial-lingual dyskinesia with N-methyl-D-aspartate receptor encephalitis and faciobrachial dystonic seizures with leucine-rich glioma-inactivated protein 1 encephalitis. Early diagnosis and treatment, especially for autoantibodies targeting neuronal surface antigens, can improve prognosis. In contrast, the presence of autoantibodies against intracellular neuronal agents warrants screening for underlying malignancy. However, early clinical diagnosis is challenging because these diseases can be misdiagnosed. In this article, we review the distinctive clinical phenotypes, magnetic resonance imaging findings, and current treatment options for autoimmune-mediated encephalitis.
-
Citations
Citations to this article as recorded by 
- A case of corticobasal syndrome possibly associated with anti-Yo antibodies
Efthalia Angelopoulou, Vasilios C. Constantinides, Evangelos Koumasopoulos, Evangelia Stanitsa, Efstratios-Stylianos Pyrgelis, Andreas Kyrozis, Elisabeth Kapaki, Leonidas Stefanis, Sokratis G. Papageorgiou Current Medical Research and Opinion.2024; 40(10): 1737. CrossRef - Movement disorders in autoimmune encephalitis: Clinical spectrum, prognosis, and outcomes from an Indian cohort
Shreyashi Jha, Netravathi M, Vikram Venkappayya Holla, Nitish Kamble, Anita Mahadevan, Pramod Kumar Pal Annals of Movement Disorders.2024; 7(3): 189. CrossRef
|